Susan Hasty, Publisher
Table of Contents . . . April 22nd, 1996Non-Subscriber - Summaries Only
DNA Vaccines (HSV) - DNA Immunization Reduces HSV-2 Disease Burden and Recurrence
AIDS Therapies (GEM 91) - Trial of Injectable Formulation of GEM 91 Initiated
Antisense Technology - Antitumor Effect Exhibited by c-myc Antisense Phosphorothioate Oligodeoxynucleotides
Antisense Technology - Phase I Trials Initiated To Inhibit C-raf Kinase Inhibition
Conference Coverage (CHI Vaccines) - Antigen-Enhanced Bacteria Improve Inactivated Whole-Cell Vaccines
Conference Coverage (CHI Vaccines) - Chimeric Mengo Virus Vaccines for HIV, Malaria, and More
Conference Coverage (IBC Vaccines) - Self Vs. Non-Self Model of Immunity Rejected
HIV Gene Therapy - Gene Transfer Prolongs T-Cell Survival
Obesity (Animal Models) - Cloning of Mouse Tub Gene and Human Homologue Finding Described
Obesity (Animal Models) - Gene Discovery May Provide Important Model
Tumor Suppressor Genes - Role of P16 Gene Confirmed in Transgenic Mice
Vascular Tissue - Local Expression of Recombinant Hirudin Reduces Neointima Formation
Vectors (Baculovirus) - Insect Vector Successfully Transduces Mammalian Liver Cells
Werner's Syndrome - Premature Aging Gene Discovered
Malaria Vaccine - "A Vaccine Trial Against Pre-Erythrocytic Stages of Plasmodium falciparum In Chimpanzees: Correlation Between Protective Efficacy after Challenge and T-Cell Activation Elicited by a PreDASH
Therapy (HIV) - "Gene Therapy for HIV Infection."
Antisense Technology - "Permanent Inhibition of Angiotensinogen Synthesis by Antisense RNA Expression."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.